SCHEMBL25664151

SCHEMBL25664151

c1ccc(-c2ccc(-c3ccc4cc(-c5nc(-c6ccc(-c7ccc(-c8cccc9c(-c%10nc(-c%11ccc%12ccccc%12c%11)nc(-c%11cccc%12oc%13ccccc%13c%11%12)n%10)cccc89)cc7)cc6)nc(-c6cccc7oc8ccccc8c67)n5)ccc4c3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 3/20 0.40
TP53 P04637 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPT P10636 3/20 0.37
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
ATM Q13315 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26260417 0.99 ALDH1A1 (0.39) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL26231380 0.96 PLA2G2A (0.37) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL22483253 0.96 ALDH1A1 (0.43) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL21108852 0.96 ALDH1A1 (0.43) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL24372500 0.96 ALDH1A1 (0.40) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL24372502 0.96 ALDH1A1 (0.43) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL24890017 0.95 ALDH1A1 (0.40) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL24315077 0.95 ALDH1A1 (0.40) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL25668493 0.95 ALDH1A1 (0.42) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL26260307 0.95 ALDH1A1 (0.39) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230157156-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230157156-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, VDAC2, ICOSLG ALDH1A1 604/4885KDM4E 892/4885TP53 3514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.